Evidence map›Paper›PMID 42560999›Full record

ArticlePloS one2026

A feasibility study of behavioural activation for haemodialysis: The BEACH study protocol.

Claire Carswell, Susan Metcalfe, Roseline Agyekum, Fez Awan, Sunil Bhandari, Kate Bramham, Joseph Chilcot, Joe Millar, Lina Gega

Abstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire CarswellDepartment of Health Sciences, University of York, York, United Kingdom.ORCID https://orcid.org/0000-0003-3781-3286
Susan MetcalfeTees, Esk and Wear Valleys NHS Foundation Trust, York, United Kingdom.
Roseline AgyekumKing's College Hospital, London, United Kingdom.
Fez AwanPatient and Public Involvement Co-investigator, Patient Advisory Group Member, Kidney Research UK, Peterborough, United Kingdom.
Sunil BhandariHull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
Kate BramhamKing's College Hospital, London, United Kingdom.
Joseph ChilcotKing's College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-6427-4690
Joe MillarTees, Esk and Wear Valleys NHS Foundation Trust, York, United Kingdom.
Lina GegaDepartment of Health Sciences, University of York, York, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople with kidney failure receiving haemodialysis experience significantly high rates of depression. However, there is a lack of evidence on how to treat depression in this population. A significant barrier to effective treatment is the high treatment burden of haemodialysis, which makes additional appointments prohibitive. Behavioural activation (BA) is an evidence-based brief therapy for depression that has been delivered in a variety of different clinical settings. However, it has not previously been evaluated in the haemodialysis setting.

methodsThis study aims to evaluate the feasibility and acceptability of a cluster randomised controlled trial (cRCT) of intradialytic BA for people with kidney failure. The study consists of three main components: A pilot cRCT, where we will recruit 52 people who are receiving haemodialysis and experiencing symptoms of depression across two sites. Patients will be cluster-randomised to either BA or usual care and will be followed up for three months; a qualitative process evaluation using semi-structured interviews to explore the experiences of patients, healthcare professionals and carers; and a feasibility economic evaluation exploring the feasibility of collecting healthcare resource use data.

resultsKey findings will include the feasibility of screening and recruiting participants, participant retention, completion of clinical outcome measures, and the acceptability of the intervention.

conclusionIf feasible, the next step will be to conduct a definitive, adequately powered cRCT to determine the effectiveness of the intervention in this population, so that we can improve the identification and management of depression for people with kidney failure.

Indexed as

Behavior TherapyDepressionKidney Failure, ChronicRenal DialysisFeasibility StudiesFemaleHumansMaleRandomized Controlled Trials as Topic

Identifiers

PMID42560999
PMCPMC13446654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.